Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
about
The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysisClostridium difficile in the ICU: the struggle continuesAcid suppression and the risk of Clostridium difficile infectionSystematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection[Clostridium difficile infections in geriatric patients].Incidence of Campylobacter and Salmonella infections following first prescription for PPI: a cohort study using routine data.Use of data envelopment analysis to quantify opportunities for antibacterial targets for reduction of health care-associated Clostridium difficile infection.Perils and pitfalls of long-term effects of proton pump inhibitors.Proton pump inhibitor use before percutaneous endoscopic gastrostomy is associated with adverse outcomes.A methodological protocol for selecting and quantifying low-value prescribing practices in routinely collected data: an Australian case study.Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.Hematologic diseases: high risk of Clostridium difficile associated diarrheaClostridium difficile infection in older adultsIncidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.Adverse effects of long-term proton pump inhibitor therapy.Clostridium difficile infection in the inflammatory bowel disease patient.Use of proton pump inhibitors after antireflux surgery: a nationwide register-based follow-up study.The association between histamine 2 receptor antagonist use and Clostridium difficile infection: a systematic review and meta-analysis.Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature.Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias.Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.Proton pump inhibitor use in the U.S. ambulatory setting, 2002-2009Automated surveillance for ventilator-associated events.Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients.Improving appropriateness of acid-suppressive medication use via computerized clinical decision support.Incidence and risk factors of recurrent acute lung injuryProton-pump inhibitor use is associated with lower urinary magnesium excretionAcid-suppressive medication use and the risk for nosocomial gastrointestinal tract bleeding.Clostridium difficile Infection and Inflammatory Bowel Disease: A Review.Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients.In vitro effect of pantoprazole on lower esophageal sphincter tone in rats.Clinical predictors of fulminant colitis in patients with Clostridium difficile infection.Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based StudyInappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis.Setting a research agenda for medical overuse.Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care Access.Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoeaFDA drug safety communications: a narrative review and clinical considerations for older adults
P2860
Q21090577-4B85837F-D058-4685-9587-C2EF14ED4DF3Q26823000-D01C448D-C663-4821-8C63-DC2312CCD0A1Q26823599-F44E76F1-C797-4E4A-A000-DAA38DCCF30AQ26849521-678716AF-8757-405F-BBB6-9171C26BD767Q30244040-9EF7954C-7394-4FFA-8EE9-A7CC60BE5610Q30616899-BAEA70C4-9436-4C64-BB6D-4BE539CD47A6Q30666603-96C61876-606D-4B43-95B6-502E9A4AB141Q33409626-2854D735-1855-4A36-86F4-FF537BF97086Q33633645-2E2E2994-DE56-45EE-8ABA-D1783C87E21EQ33634843-3BAD8475-7079-4C46-B606-DD6D0F87B239Q33666086-B492163A-40D8-4AB1-9BA3-0A7E78E4D62EQ33718326-FEC1CA8C-DF01-4952-9FDA-5F70D2915529Q33771594-EA74496A-3DB1-4A18-9049-E8F641DFFB2EQ33962541-D84EB04F-BB5A-4023-BE09-E6F0D8227529Q34167899-6BB6B18C-BD62-4D58-8CF1-0954FD042F0CQ34234668-504976BA-D4DE-404D-B83C-C3202467ECFAQ34237263-6B47BE24-147D-4A90-9274-EE18848B6F87Q34331595-05A51AC8-2F57-4855-A0AC-C886800091A8Q34342981-29EF27D8-87ED-4C4C-B3FD-E38EBF7030C9Q34400622-64346A54-2D18-4296-B42E-D8C417BCF139Q34510524-12837D9A-91F3-480D-A769-65A1890D6316Q34552205-5DFF3B25-0B5C-44C4-99C8-F015B2389ADEQ34589801-ABC95CB3-0CD0-40FC-9035-7A990095D4B5Q34609950-E79652DC-04A4-4531-84F0-E3B510A38697Q34951199-6B9E0CCB-3833-4327-8CF6-0AF678A0D4DCQ34998974-62809FAC-64AC-40F6-88A3-9A0D4D20C35FQ35007508-FAF4BA67-3CD6-4E1F-B38E-11049F22AE92Q35038136-4E2F1499-09A6-41EC-911E-C2457E7BD725Q35124639-AB8B3570-68AF-4E8E-8593-2386DDA5AFADQ35208564-4C0B98DE-DF51-49A6-AC63-CCFCE054A972Q35579344-7CEB0185-9AC6-4430-B924-F4FB7BF27B70Q35606827-32D58B4B-0255-457A-B6ED-AB1F0314B6F2Q35890562-0C8571C5-2DDE-4B43-90C9-5905357FB836Q35997157-E72EA8E8-A84D-41FC-8359-2FFF8070D6EBQ35999704-EB91090F-AA10-4566-8AA1-2319119EA659Q36020653-0395CE79-E4C2-4184-A56A-2482D908A7DBQ36040629-5F73C8A3-DF01-4E6B-9487-A1FF65F48DDDQ36076042-D722ED0E-0011-4D69-B2A7-FAFA4D5B831CQ36140398-3F6E58F9-137A-4E25-8A7E-8BF74876BA47Q36146850-01DE39D2-3C17-40C9-8684-47D25210BD7E
P2860
Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@ast
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@en
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@nl
type
label
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@ast
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@en
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@nl
prefLabel
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@ast
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@en
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@nl
P2093
P1476
Iatrogenic gastric acid suppre ...... ostridium difficile infection.
@en
P2093
Daniel Talmor
Diane Soulliard
Lena Novack
Michael D Howell
Philip Grgurich
Victor Novack
P304
P356
10.1001/ARCHINTERNMED.2010.89
P407
P577
2010-05-01T00:00:00Z